Immuron Revenue

Immuron had revenue of 3.99M AUD in the half year ending December 31, 2024, with 584.38% growth. This brings the company's revenue in the last twelve months to 6.54M, up 82.90% year-over-year. In the fiscal year ending June 30, 2024, Immuron had annual revenue of 4.90M with 171.67% growth.

Revenue (ttm)

6.54M

Revenue Growth

+82.90%

P/S Ratio

2.29

Revenue / Employee

934.52K

Employees

Market Cap

14.97M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.90M	3.10M	171.67%
Jun 30, 2023	1.80M	1.04M	135.85%
Jun 30, 2022	765.19K	619.42K	424.91%
Jun 30, 2021	145.78K	-2.37M	-94.21%
Jun 30, 2020	2.52M	131.14K	5.49%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro
Jun 30, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CSL Limited	24.61B
Pro Medicus	184.58M
Cochlear	2.31B
Sonic Healthcare	9.33B
Ramsay Health Care	17.12B
Telix Pharmaceuticals	783.21M
Ansell	3.00B
Regis Healthcare	1.10B

Revenue Rankings

Immuron News

6 weeks ago - Immuron Letter to Shareholders: Projects Update - GlobeNewsWire
3 months ago - Immuron (IMRN) Achieves Record Sales Milestone - GuruFocus
3 months ago - Immuron exceeds AUD$5 million in sales in a fiscal year - Seeking Alpha
3 months ago - Immuron Travelan® highest sales in history - GlobeNewsWire
4 months ago - Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - GlobeNewsWire
6 months ago - Immuron Travelan® continued strong sales growth - GlobeNewsWire
6 months ago - Immuron Announces New Research Collaboration targeting Antimicrobial Resistance - GlobeNewsWire
6 months ago - Immuron Announces Travelan® Clinical Trial Update - GlobeNewsWire

More News